Cytomegalovirus Uveitis: Taiwan expert consensus

J Formos Med Assoc. 2023 Aug;122(8):668-674. doi: 10.1016/j.jfma.2023.03.014. Epub 2023 Mar 30.

Abstract

Cytomegalovirus (CMV) uveitis, a type of herpetic uveitis, is a major cause of infectious uveitis. Anterior and posterior CMV uveitis have diverse clinical presentations and treatment modalities. Based on expert consensus in Taiwan, this article provides suggestions regarding clinical manifestations, diagnosis, and treatment strategies for CMV uveitis based on clinical practice experience in Taiwan. CMV uveitis may have a distinct clinical presentation. Polymerase chain reaction (PCR) is an essential diagnostic tool to confirm a diagnosis. Antiviral therapy is the mainstay of treatment. Different agents, routes, and other supplemental treatments have been summarized and discussed in this article. Early diagnosis and appropriate treatment of CMV uveitis are crucial to avoid irreversible complications and vision loss. This consensus provides practical guidelines for ophthalmologists in Taiwan.

Keywords: CMV; Consensus; Herpetic virus; Taiwan; Uveitis.

Publication types

  • Practice Guideline

MeSH terms

  • Consensus
  • Cytomegalovirus / genetics
  • Cytomegalovirus Infections* / diagnosis
  • Cytomegalovirus Infections* / drug therapy
  • DNA, Viral
  • Eye Infections, Viral* / diagnosis
  • Eye Infections, Viral* / drug therapy
  • Humans
  • Taiwan
  • Uveitis* / diagnosis
  • Uveitis* / drug therapy
  • Uveitis* / etiology
  • Uveitis, Anterior* / diagnosis
  • Uveitis, Anterior* / drug therapy

Substances

  • DNA, Viral